Anti-Aging

Epithalon

Epitalon, Epithalone, Tetrapeptide ALA-GLU-ASP-GLY, Epithalamin synthetic analogue

Epithalon is a synthetic tetrapeptide derived from the pineal gland that activates telomerase — the enzyme that extends telomeres — and has been studied for over 40 years in Russian anti-aging and longevity research. It also normalizes melatonin production, improves circadian rhythm, and demonstrates antioxidant and anti-tumor effects.

Subcutaneous (SubQ) Intranasal Beginner Friendly
Save
This peptide profile is for research and educational purposes only. Not intended for human use or self-administration.

Overview

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (4 amino acids: Ala-Glu-Asp-Gly) derived from epithalamin — a polypeptide extract of the bovine pineal gland. Developed in the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson over four decades of research, epithalon is one of the most studied peptides in the field of anti-aging and longevity research. Its most notable documented effect is the activation of telomerase — the enzyme that extends telomeres, the protective caps on chromosomes that shorten with each cell division. In human and animal studies, epithalon has been shown to increase telomere length, slow biological aging, and reduce age-associated pathologies.

Mechanism of Action

Epithalon's primary anti-aging mechanism is the induction of telomerase (hTERT — human telomerase reverse transcriptase) activity. Telomeres naturally shorten with each cell replication cycle, eventually triggering cellular senescence or apoptosis. By activating telomerase, epithalon can extend telomere length, theoretically resetting the replicative clock of aging cells. In the pineal gland, epithalon restores melatonin production that typically declines with age, improving circadian rhythm regulation and sleep quality. It also exhibits powerful antioxidant effects, reducing lipid peroxidation and reactive oxygen species in multiple tissue types. In carcinogenesis research, epithalon has demonstrated an inhibitory effect on chemically-induced tumor development in rodent models, possibly due to its DNA-stabilizing and anti-mutagenic properties. Additionally, it normalizes the function of the hypothalamic-pituitary axis and regulates cortisol and other hormonal secretion patterns in aging models.

Key Research

Epithalon research spans 40+ years, primarily from the Institute of Bioregulation and Gerontology in St. Petersburg under Professor Vladimir Khavinson. Published studies in peer-reviewed journals document telomerase activation, telomere elongation, and life extension in mouse models. A landmark study in normal diploid human cells demonstrated that epithalon induced telomerase activity and extended telomere length, enabling cells to divide beyond their Hayflick limit. Animal longevity studies showed 30–40% increased survival compared to controls. Clinical studies in elderly patients documented improved immune function, reduced incidence of respiratory infections, normalized melatonin levels, and improved circadian rhythm. Anti-tumor effects have been documented in chemically-induced cancer models. Over 100 peer-reviewed publications support its mechanisms.

View full research index →

Research Dosing

Typical Dose

5–10 mg per day for 10–20 day cycles

Half-Life

~30 minutes (rapidly distributes to pineal and other tissues

Standard research protocols use course-based administration rather than daily indefinite dosing. A typical course is 5–10 mg per day administered subcutaneously or intravenously for 10–20 consecutive days, 1–2 times per year. The most common clinical protocol used in Russian research is 10 mg/day SC for 10 days, twice yearly. Intranasal administration at 20–50 mcg per nostril has also been studied, though subcutaneous injection is considered the gold standard route. Lower-dose protocols of 5 mg/day for 20 days once or twice annually are also used. There is no established loading dose requirement. Morning or evening dosing is both acceptable — many researchers prefer morning to avoid melatonin-related drowsiness.
Open Dosage Calculator

Protocols

Classic Anti-Aging Protocol: 10 mg/day SC for 10 days, twice per year (spring and autumn). Telomere Restoration Protocol: 10 mg/day for 20 consecutive days, once annually. Combined Longevity Stack: Epithalon 10 mg/day + GHK-Cu 200 mcg/day for 20 days, twice yearly — targeting both telomere biology and collagen/tissue regeneration simultaneously.

Reported Side Effects

Side effects summarized from animal studies and researcher community observations. Educational purposes only — not medical advice.
Epithalon is one of the safest peptides in the research literature. Over 40 years of Khavinson's clinical research involving thousands of patients has documented no serious adverse events. The most commonly noted effects are dose-dependent sleepiness (particularly at evening doses, consistent with melatonin normalization), mild injection site redness, and occasional vivid dreams. Some individuals report an initial brief period of fatigue in the first few days, consistent with cellular and mitochondrial reorganization. Importantly, while epithalon activates telomerase — which could theoretically support cancer cell immortality — studies have paradoxically shown anti-tumor and tumor-suppressive effects in animal models, possibly due to its broader DNA-stabilizing effects. Nonetheless, its use is typically avoided in individuals with a history of cancer until more data is available.

Storage & Handling

Store lyophilized epithalon at -20°C for long-term storage (up to 24 months). Short-term storage at 2–8°C is acceptable for up to 3 months. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 14–21 days. Epithalon is sensitive to degradation — protect from repeated temperature changes, light exposure, and air. Reconstitute gently by adding BAC water along the inside wall of the vial and swirling slowly — avoid vigorous shaking.